Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Non-Current Debt (2024 - 2025)

Historic Non-Current Debt for Editas Medicine (EDIT) over the last 2 years, with Q3 2025 value amounting to $54.1 million.

  • Editas Medicine's Non-Current Debt changed N/A to $54.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.1 million, marking a year-over-year change of. This contributed to the annual value of $52.4 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Editas Medicine's Non-Current Debt stood at $54.1 million.
  • In the past 5 years, Editas Medicine's Non-Current Debt ranged from a high of $54.1 million in Q3 2025 and a low of $49.6 million during Q1 2025